MRC1 and bladder transitional cell carcinoma: For example, somatic mutations of MMR genes were associated with better clinical outcomes in BLCA, LUAD, SKCM, and STAD (FDR < 0.035), but associated with worse survival of head and neck squamous cell carcinoma (HNSC) (FDR = 0.038).